Planta San Javier
FDA import alert and refusal historySanta Cruz, BoliviaFEI 3004150168
As of October 25, 2026, Planta San Javier (Santa Cruz, Bolivia) is on the red list of FDA Import Alert 99-43 (Ready-to-eat foods: insanitary conditions) for cheese/cheese products, published by FDA on August 28, 2025, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-43 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Planta San Javier
1 record, newest first. Each line links to the FDA page it came from.
2025
- Import alert listingListed on Import Alert 99-43red listCheese/Cheese ProductsSource
Questions about Planta San Javier
- Is Planta San Javier on an FDA import alert?
- Yes. As of October 25, 2026, Planta San Javier is on the red list of FDA Import Alert 99-43, “Ready-to-eat foods: insanitary conditions”, for cheese/cheese products; FDA published the listing on August 28, 2025.
- Has FDA refused shipments from Planta San Javier?
- No FDA import refusals for Planta San Javier appear in FDA's refusal data since October 2016, as of October 25, 2026.
- What is Planta San Javier's FEI number?
- Planta San Javier's FDA Establishment Identifier (FEI) is 3004150168.
- Can shipments from Planta San Javier still enter the U.S.?
- Shipments of cheese/cheese products from Planta San Javier can be detained without physical examination under Import Alert 99-43; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Planta San Javier?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.